chr8-143650332-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001261843.2(ZNF623):c.340G>A(p.Asp114Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,614,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001261843.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF623 | ENST00000526926.6 | c.340G>A | p.Asp114Asn | missense_variant | Exon 2 of 2 | 2 | NM_001261843.2 | ENSP00000435232.1 | ||
ZNF623 | ENST00000458270.2 | c.340G>A | p.Asp114Asn | missense_variant | Exon 2 of 2 | 1 | ENSP00000411139.2 | |||
ZNF623 | ENST00000501748.3 | c.460G>A | p.Asp154Asn | missense_variant | Exon 1 of 1 | 6 | ENSP00000445979.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152218Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000597 AC: 15AN: 251148 AF XY: 0.0000884 show subpopulations
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461894Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 727248 show subpopulations
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74488 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.460G>A (p.D154N) alteration is located in exon 1 (coding exon 1) of the ZNF623 gene. This alteration results from a G to A substitution at nucleotide position 460, causing the aspartic acid (D) at amino acid position 154 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at